High Cardiac Risk of E-cigarettes: Russian Expert

Industry Insight by 2FIRSTS.ai

Dec.06.2023

High Cardiac Risk of E-cigarettes: Russian Expert

E-cigarette use increases cardiovascular disease risk, raises the chance of heart attacks and strokes by 56% and 33% respectively, warns Russian expert.

According to recent news from A42.RU, Dr. Aleksey Alekseyevichkov, head of cardiology at Kuzbass, Russia, and a candidate for medical science, has stated that e-cigarettes are extremely harmful, including a significant increase in the risk of cardiovascular diseases.

He emphasized that e-cigarettes are more likely to cause heart disease and stroke compared to regular cigarettes, with users facing a 56% increased risk of heart attacks and a one-third increased risk of stroke.

According to Alekseyevko, e-cigarette use can lead to the loss of elasticity in blood vessel walls, affecting oxygen supply and making users more prone to symptoms such as irregular heartbeat, chest pain, and rapid heart rate. Additionally, toxic substances produced by e-cigarettes can increase the risk of blood clotting and arterial hardening, with higher risk observed among women.

References:

[1] Главный кардиолог Кузбасса рассказал о связи курения вейпов и сердечного приступа

Also Read:

[1] Russian Duma Proposes Criminalizing Tobacco and Nicotine Advertising

[2] Russia Implements Label Requirement for E-Cigarettes and E-Liquids

[3] Russia Takes Action: Monitoring Enforcement of E-cigarette Sales Ban to Minors

#Europe #Open system e-cigarettes #Disposable e-cigarettes #Public health #Russia #E-cigarette #E-cigarettes and Tobacco

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Swedish Oral Pouch Manufacturer WiJo to Establish U.S. Production Base, Targeting March 2026 Start-Up

Swedish oral pouch manufacturer WiJo Pouches has announced plans to establish its first North American production facility in South Carolina, where it will lease a manufacturing site to produce nicotine, caffeine and functional pouch products. The project, expected to begin operations in March 2026 and create about 170 jobs, has secured tax incentive support from both state and county authorities.

Dec.05 by 2FIRSTS.ai

RLX Technology Inc. (NYSE: RLX) Q3 2025 Financial Results: Net Revenue US$158.6 Million; International Business Accounts for 72%

RLX Technology Inc. (NYSE: RLX) announced its unaudited financial results for the third quarter of 2025. The company reported net revenue of RMB 1.13 billion, up 49.3% year-on-year, and adjusted net profit of RMB 295.4 million, up 1.4% quarter-on-quarter. International business contributed 72% of total revenue, reflecting robust financial performance and continued shareholder returns.

Nov.14

Indonesia’s Statistics Agency: Bali Leads Nation in E-Cigarette Use; Urban Usage Climbing Sharply

Indonesia’s statistics agency (BPS) reports in its latest publication, Statistics of People’s Welfare 2025, that Bali has the highest share of daily e-cigarette users at 1.66%, followed by East Kalimantan (1.59%) and the Special Region of Yogyakarta (1.24%). Daily vaping prevalence is higher in urban areas (0.77%) than in rural areas (0.53%).

Oct.16

Virginia Seeks to Dismiss E-Cigarette Ban Challenge, Citing Lack of Legal Standing

The Virginia Attorney General and tax commissioner have urged a federal court to dismiss a lawsuit challenging the state’s ban on unapproved e-cigarettes, arguing that the companies behind the suit lack legal standing since their products are federally illegal. The state contends the plaintiffs, Novo Distro Inc. and Tobacco Hut and Vape Fairfax Inc., have no lawful right to sell unapproved vapes and cannot show irreparable harm.